Serum Cholinesterases, Paraoxonase, and Cardiovascular Risk After Intravitreal Bevacizumab

Clinical trial NCT07550777 · RECRUITING

Trial details

NCT number: NCT07550777
Sponsor: Ataturk University
Status: RECRUITING
Study type: OBSERVATIONAL

Diabete Mellitus Retina Vein Occlusion Age Macular Degeneration

Start date: 2025-11-03
Primary completion: 2026-06-10
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.